Clinical Trials on Sedation in Argentina

Total 8 results

Hospital Italiano de Buenos Aires

Active, not recruiting

BIS-Guided Sedation in Critically Ill Patients Under Deep Sedation

Delirium | Sedative Overdose

Argentina
Cochlear

Terminated

Cochlear Response Telemetry and Hearing Preservation (CREST)

Hearing Impairment, Sensorineural

Argentina
Hospital Italiano de Buenos Aires

Unknown

Cochlear Electrical Impedance and the Effect of Topical Dexamethasone on Cochlear Implant Surgery

Sensorineural Hearing Loss | Cochlear Implant

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Cochlear Trauma, Functional and Structural Preservation in Cochlear Implant Surgery

Hearing Loss | Cochlear Implant | Cochlear Microphonics | Electrocochleography

Argentina
Novartis Pharmaceuticals

Terminated

Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

Major Depressive Disorder With Suicidal Ideation With Intent

Taiwan, Spain, Germany, Netherlands, Turkey, Mexico, United States, Malaysia, Poland, Canada, Japan, Russian Federation, Argentina, Brazil
Cochlear

Terminated

Observation of Benefits for Patients Implanted With a Hearing Implant of the Company Cochlear (IROS)

Hearing Loss

Spain, South Africa, France, Germany, Netherlands, Turkey, Belgium, Poland, Hungary, Portugal, Sweden, Argentina, Austria, Brazil, Colombia, Slovenia
Janssen Research & Development, LLC

Completed

54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide (Aspire II)

Depressive Disorder, Major

United States, Belgium, Canada, Poland, France, Spain, Brazil, Lithuania, Czechia, Austria, Argentina, Turkey
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (KESTREL)

Diabetic Macular Edema

United States, Austria, Japan, Australia, Spain, Canada, Israel, Netherlands, Italy, United Kingdom, Portugal, Colombia, Puerto Rico, Argentina

Clinical Trials on Sedation in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations